DK1017404T3 - Farmaceutisk sammensætning til behandling af inflammatorisk tarmsygdom - Google Patents

Farmaceutisk sammensætning til behandling af inflammatorisk tarmsygdom

Info

Publication number
DK1017404T3
DK1017404T3 DK98944115T DK98944115T DK1017404T3 DK 1017404 T3 DK1017404 T3 DK 1017404T3 DK 98944115 T DK98944115 T DK 98944115T DK 98944115 T DK98944115 T DK 98944115T DK 1017404 T3 DK1017404 T3 DK 1017404T3
Authority
DK
Denmark
Prior art keywords
treatment
pharmaceutical composition
inflammatory bowel
bowel disease
disease
Prior art date
Application number
DK98944115T
Other languages
Danish (da)
English (en)
Inventor
Jean-Pierre Sachetto
William Jeffery Sandborn
William John Tremaine
Original Assignee
Celltech Pharma Europ Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9720590.0A external-priority patent/GB9720590D0/en
Priority claimed from GBGB9725346.2A external-priority patent/GB9725346D0/en
Application filed by Celltech Pharma Europ Ltd filed Critical Celltech Pharma Europ Ltd
Application granted granted Critical
Publication of DK1017404T3 publication Critical patent/DK1017404T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/723—Xanthans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK98944115T 1997-09-26 1998-09-25 Farmaceutisk sammensætning til behandling af inflammatorisk tarmsygdom DK1017404T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9720590.0A GB9720590D0 (es) 1997-09-26 1997-09-26
GBGB9725346.2A GB9725346D0 (en) 1997-11-28 1997-11-28 Pharmaceutical composition for the treatment of inflammatory bowel disease
EP98944115A EP1017404B1 (en) 1997-09-26 1998-09-25 Pharmaceutical composition for the treatment of inflammatory bowel disease
PCT/GB1998/002899 WO1999016454A1 (en) 1997-09-26 1998-09-25 Pharmaceutical composition for the treatment of inflammatory bowel disease

Publications (1)

Publication Number Publication Date
DK1017404T3 true DK1017404T3 (da) 2004-11-01

Family

ID=26312333

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98944115T DK1017404T3 (da) 1997-09-26 1998-09-25 Farmaceutisk sammensætning til behandling af inflammatorisk tarmsygdom

Country Status (11)

Country Link
US (1) US7341741B1 (es)
EP (1) EP1017404B1 (es)
JP (2) JP4180791B2 (es)
AT (1) ATE269710T1 (es)
AU (1) AU758501B2 (es)
CA (1) CA2304948C (es)
DE (1) DE69824748T2 (es)
DK (1) DK1017404T3 (es)
ES (1) ES2224428T3 (es)
PT (1) PT1017404E (es)
WO (1) WO1999016454A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0469061A1 (en) 1989-04-21 1992-02-05 E.I. Du Pont De Nemours And Company Fungicidal oxazolidinones
US6166024A (en) 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
CA2294988C (en) 1997-07-01 2015-11-24 Isis Pharmaceuticals Inc. Compositions and methods for the delivery of oligonucleotides via the alimentary canal
AU745880B2 (en) * 1998-05-21 2002-04-11 Isis Pharmaceuticals, Inc. Compositions and methods for non-parenteral delivery of oligonucleotides
IT1301947B1 (it) * 1998-07-28 2000-07-20 Chiesi Farma Spa Formulazioni farmaceutiche di beclometasone dipropionato per iltrattamento di malattie infiammatorie croniche della mucosa
DE19850445A1 (de) * 1998-11-02 2000-05-04 Falk Pharma Gmbh Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
AUPP915099A0 (en) * 1999-03-12 1999-04-15 Monk, Michael Mendel Improved composition for oral administration
FI119429B (fi) * 2002-09-17 2008-11-14 Danisco Hiilihydraattien uusi käyttö ja koostumukset
WO2004071453A2 (en) 2003-02-13 2004-08-26 Isis Pharmaceuticals, Inc. Compositions and methods for treatment of pouchitis
WO2006028012A1 (ja) * 2004-09-07 2006-03-16 Hakuto Co., Ltd. 化粧料およびその製造方法
US7541384B2 (en) 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US8436051B2 (en) * 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
SI2294012T1 (sl) * 2008-05-07 2014-11-28 Salix Pharmaceuticals, Ltd. Dajanje ÄŤistila za ÄŤrevo in antibiotika za zdravljenje ÄŤrevesne bolezni
AU2009315898B2 (en) 2008-11-13 2015-07-23 Nogra Pharma Limited Antisense compositions and methods of making and using same
GB0823472D0 (en) * 2008-12-23 2009-01-28 Photocure Asa Product
US9402968B2 (en) 2012-07-11 2016-08-02 Mercy Medical Research Institute, Inc. Colorectal delivery device
WO2014154677A1 (en) * 2013-03-25 2014-10-02 Ferring Bv Composition for the treatment of disease
WO2018191752A1 (en) 2017-04-14 2018-10-18 Gelesis Llc Compositions and methods for treating or preventing gut permeability-related disorders
WO2021096479A1 (en) * 2019-11-11 2021-05-20 Trim-Edicine, Inc. Treatment for inflammatory bowel disease and radiation-induced intestinal injury

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3924570A1 (de) 1989-07-25 1991-01-31 Henning Berlin Gmbh Pharmazeutische zubereitung zur rektalen verabreichung
WO1992016214A1 (en) 1991-03-15 1992-10-01 Norwich Eaton Pharmaceuticals Inc. The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
WO1992021324A1 (de) * 1991-06-07 1992-12-10 Byk Nederland Bv Pharmazeutische klistierzubereitung
FR2692484B1 (fr) * 1992-06-22 1995-06-30 Gouchet Franck Nouvelle forme galenique de 4-asa a liberation controlee.
WO1995016451A1 (fr) 1992-06-22 1995-06-22 Franck Arno Gouchet Comprimes a liberation controlee de 4-asa
US5380522A (en) 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
GB9414699D0 (en) * 1994-07-21 1994-09-07 Slagel David Aqueous foamable composition
US5691343A (en) * 1995-03-30 1997-11-25 Mayo Foundation For Medical Education And Research Use of topical azathioprine to treat inflammatory bowel disorders
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
SE9602644D0 (sv) 1996-07-04 1996-07-04 Astra Ab New use

Also Published As

Publication number Publication date
JP4180791B2 (ja) 2008-11-12
JP2008143914A (ja) 2008-06-26
AU758501B2 (en) 2003-03-20
EP1017404A1 (en) 2000-07-12
US7341741B1 (en) 2008-03-11
PT1017404E (pt) 2004-11-30
ES2224428T3 (es) 2005-03-01
EP1017404B1 (en) 2004-06-23
DE69824748T2 (de) 2005-08-25
DE69824748D1 (de) 2004-07-29
AU9178098A (en) 1999-04-23
CA2304948C (en) 2009-12-29
ATE269710T1 (de) 2004-07-15
JP2001517708A (ja) 2001-10-09
WO1999016454A1 (en) 1999-04-08
CA2304948A1 (en) 1999-04-08

Similar Documents

Publication Publication Date Title
DK1017404T3 (da) Farmaceutisk sammensætning til behandling af inflammatorisk tarmsygdom
TWI256389B (en) Novel hPPAR delta agonists and pharmaceutical compositions comprising the same
NL300389I1 (nl) Thiofeensulfonamiden die bruikbaar zijn als carbo-anhydraseremmers.
WO2001035950A3 (en) Benzamide therapeutics and methods for treating inflammatory bowel disease
FI964681A0 (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
DE19875032I2 (de) Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
NL300224I1 (nl) 3-Benzazepinzonen gesubstitueerd met een benzocyclobutyl-of indanylalkyla-minoalkylgroep, bruikbaar voor de behandeling van cardiovasculaire aandoeningen.
NO974911D0 (no) Fremstilling og anvendelse av sulfaterte oligosakarider
NO951198D0 (no) Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene
DK0490649T3 (da) En fysisk form af N- 4- 5-(cyklopentyloxycarbonylamino)-1-methylindol-3-ylmethyl -3-methoxybenzoyl -2-methylbenzensulfonamid, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende den
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
MX9202413A (es) Composiciones acuosas de citrato de calcio.
EA200200890A1 (ru) Применение ингибиторов il-18
FI931490A0 (fi) Detergentkompositioner, vilka med avseende pao sura komponenter av endoglukanastyp innehaoller anrikade cellulaskompositioner
DK0871434T4 (da) Oralt farmaceutisk sammensætning med modificeret frigivelse indeholdende 5-ASA og fremgangsmåde til behandling af tarmsygdomme
EP0529931A3 (en) Water modifier
DE69104292T2 (de) Manschettenverbindung und Rohranschlussstück.
ES2159733T3 (es) Compuestos de dialquiltiacumicina.
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
DE69624308D1 (de) Bernsteinsäurederivate als abbaubare Chelatbildner, ihre Verwendungen und Zusammensetzungen
BG102667A (en) Diosgenine-containing composition
DE69613395T2 (de) Schwefelenthaltende di-ter-butylphenol-verbindungen brauchbar als entzündungshemmende mittel
DK1017667T3 (da) 2-amino-6-methyl-7-acetyltetralin og farmaceutiske præparater til forebyggelse og terapeutisk behandling af inflammatoriske og/eller autoimmune patalogier
YU48341B (sh) Preparat herbicida
BR0016616A (pt) Microrganismos atenuados para o tratamento de infecção